Newsletter Signup | Join Community
Classification of Non-Hodgkin Lymphomas is necessary to determine treatment.
PI3K inhibitors are a promising new therapy for the management of b cell lymphomas and are being evaluated in MZL.
FDA Approves Chemoimmunotherapy Regimen for Patients with Relapsed or Refractory Diffuse Large B-cell Lymphoma
Ten things every patient with lymphoma should consider in order to get the best possible treatment
Treatment of Marginal Zone Lymphomas: MALT Lymphomas, Splenic and Marginal Zone Lymphomas. FDA approves Revlimid-Rituxan
What you need to know about CAR T cell therapy for the treatment of lymphoma, leukemia and solid tumors.
Lymphoma is a curable cancer and this continues to improve with newer precision medicines and immuntherapy
How long have people been on watch and wait before they needed treatment ?
Rituxan Maintenance; has your doctor recommended it every 2 or every 3 months?
Long-Term Follow-Up Indicates Survival with Addition of Rituxan® to CHOP in NHL
Curious is others with celiac disease have develeoped lymphoma? https://mavendoctors…